Gamma-hydroxybutyric acid: An endogenous neuromodulator with abuse potential

Trends in Pharmacological Sciences

Volumn 20, Issue 4, 1999, Pages 135-141

  Bernasconi, Raymond ^c   Mathivet, Pascal ^a   Bischoff, Serge ^b   Marescaux, Christian ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

^c University Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALCOHOL; NEUROTRANSMITTER; OPIATE;

ALCOHOLISM; ANIMAL TISSUE; BINDING SITE; BLOOD BRAIN BARRIER; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RAT; REVIEW; SIGNAL TRANSDUCTION; SLEEP DISORDER; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME; NEUROTRANSMISSION; OPIATE ADDICTION;

EID: 0033037832     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01341-3     Document Type: Short Survey

References (47)

1. 1 Bowery, N. G., Hudson, A. L. and Price, G. W. (1987) Neuroscience 20, 365-383
2. 2 Mathivet, P., Bernasconi, R., de Barry, J., Marescaux, C. and Bittiger, H. (1997) Eur. J. Pharmacol. 321, 67-75
3. 3 Ma Prog. Neurobiol. 51, 337-361
4. 4 Cash, C. D., Hechler, V., Mersel, M. and Ma Eur. J. Pharmacol. 209, 25-28
5. 5 Kaupman, K. et al. (1997) Nature 386, 239-246
6. 6 Möhler, H. and Fritschy, J-M. (1999) Trends Pharmacol. Sci. 20, 87-89
7. 7 Krogsgaard, P., Frolund, B. and Ebert, B. (1997) in The GABA Receptors (Enna, S. J. and Bowery, N. G., eds), pp. 37-81, Humana Press
8. 8 Cash, C. D. (1994) Neurosci. Biobehav. Rev. 18, 291-304
9. 9 Kaufman, E. E., Porrino, L. J. and Nelson, T. (1990) Biochem. Pharmacol. 40, 2637-2640
10. 10 Schmidt-Mutter, C., Pain, L., Sandner, G., Gobaille, S. and Ma Eur. J. Pharmacol. 342, 21-27
11. 11 Snead, O. C. (1992) J. Neural Transm. Suppl. 35, 7-20
12. 12 Mamelak, M. (1989) Neurosci. Biobehav. Rev. 13, 187-198
13. 13 Li, J., Stokes, S. A. and Woeckner, A. (1998) Ann. Emerg. Med. 31, 723-728
14. 14 Vickers, M. (1969) Int. Anesthesiol. Clin. 7, 75-89
15. 15 Nishino, S. and Mignot, E. (1997) Prog. Neurobiol. 52, 27-78
16. 16 Gallimberti, L., Schifano, F., Forza, G., Miconi, L. and Ferrara, S. (1994) Eur. Arch. Psychiatr. Clin. Neurosci. 244, 113-114
17. 17 Gallimberti, L. et al. (1989) Lancet 2, 787-789
18. 18 Kleinschmidt, S. et al. (1997) Eur. J. Anaesthesiol. 14, 590-599
19. 19 Colombo, G. et al. (1995) Eur. J. Pharmacol. 273, 235-238
20. 20 Fadda, F., Colombo, G., Mosca, E. and Gessa, G. L. (1989) Alcohol Alcoholism 24, 447-451
21. 21 Gallimberti, L., Ferri, M., Ferrara, S. D., Fadda, F. and Gessa, G. L. (1992) Alcoholism: Clin. Exp. Res. 16, 673-676
22. 22 Addolorato, G. et al. (1998) Lancet 351, 38
23. 23 Rosen, M. I., Pearsall, H. R., Woods, S. W. and Kosten, T. R. (1997) J. Subst. Abuse Treat. 14, 149-154
24. 24 Colombo, G. et al. (1995) Eur. J. Pharmacol. 285, 103-107
25. 25 Martellota, M.C., Fattore, L., Cossu, G. and Fratta, W. (1997) Psychopharmacology 132, 1-5
26. 26 Tunnicliff, G. (1997) Clin. Toxicol. 35, 581-590
27. 27 Galloway, G. P. et al. (1997) Addiction 92, 89-96
28. 28 Hernandez, M., McDaniel, C. H., Costanza, C. D. and Hernandez, O. J. (1998) Am. J. Drug Alcohol Abuse 24, 179-183
29. 29 Nutt, D. J. (1996) Lancet 341, 31-36
30. 30 Feigenbaum, J. J. and Howard, S. G. (1996) Int. J. Neurosci. 88, 53-69
31. 31 Di Chiara, G. (1995) Drug Alcohol Depend. 38, 95-137
32. 32 Feigenbaum, J. J. and Simantov, R. (1996) Neurosci. Lett. 212, 5-8
33. 33 Feigenbaum, J. J. and Howard, S. G. (1997) Neurosci. Lett. 224, 71-74
34. 34 Bernasconi, R. et al. (1992) J. Neural Transm. Suppl., 35, 155-177
35. 35 Serra, M., Sanna, E., Foddi, C., Concas, A. and Biggio, G. (1991) Psychopharmacology 104, 351-355
36. 36 Gessa, G. L., Diana, M., Fadda, F. and Colombo, G. (1993) Eur. Neuropsychopharmacol. 3, 224-225
37. 37 Snead, O. C. and Liu, C. C. (1993) Neuropharmacology 32, 401-409
38. 38 Godbout, R., Jelenic, P., Labrie, C., Schmitt, M. and Bourguignon, J. J. (1995) Brain Res. 673, 157-160
39. 39 Shoaib, M., Swanner, L. S., Beyer, C. E., Goldberg, S. R. and Schindler, C. W. (1998) Behav. Pharmacol. 9, 195-206
40. 40 Perry, H. E., Wright, R. O., Shannon, M. W. and Woolf A. D. (1998) Pediatrics 101, 1045-1048
41. 41 Marwick, C. (1997) J. Am. Med. Assoc. 277, 1505-1506
42. 42 Bowery, N. G. (1997) in The GABA Receptors (Enna, S. J. and Bowery, N. G., eds), pp. 209-236, Humana Press
43. 43 Pontieri, F. E., Tanda, G., Orzi, F. and Di Chiara, G. (1996) Nature 382, 255-257
44. 44 Hechler, V., Gobaille, S. and Ma (1992) Brain Res. 572, 348-354
45. 45 Vayer, P., Ehrhardt, J. D., Gobaille, S., Mandel, P. and Ma Neurochem. Int. 12, 53-59
46. 46 Chu, D. C. M., Albin, R. L., Young, A. B. and Penney, J. B. (1990) Neuroscience 34, 341-357
47. 47 Okada, Y., Nitsch-Hassler, C., Kim, J. S., Bak, I. J. and Hassler, R. (1971) Exp. Brain Res. 13, 514-518